ASML’s Q4 beat is not the story; the misprice is EPS quality versus a 2030 capacity signal that stayed intact

The print matters because it separates a near-term earnings disappointment from a capacity-cycle signal that did not deteriorate. What was priced in was not a weak top line: consensus expected revenue of €11,185.6 million (€11.19 billion, €11.2 billion), and ASML delivered €11,607.2 million (€11.61 billion, €11.6 billion), a +3.8% surprise. What actually surprised negatively was earnings leverage, with EPS of €8.55 versus €9.04 expected, a -5.4% surprise. That combination is easy to trade badly in the first reaction, because it says revenue exceeded the Street while EPS did not. The more useful read is that investors should not treat the EPS miss as evidence that the cycle thesis broke, since the company’s own call framed 2025 on a different reporting basis as €32.7 billion in net revenue, 52.8% gross margin, €9.6 billion of net income, and EPS “close to EUR 25 per ordinary share,” per CFO R.J.M. Dassen. Those figures should not be mixed with the Street-comparison basis, but they do show management did not respond to the EPS miss by walking away from the multi-year model.

That distinction between what was priced in and what changed is where the variant perception sits. The market can plausibly focus on a Q4 FY2025 gross margin of 52.2% and diluted EPS of €7.34 in the quarterly history, especially because Q1 FY2026 then steps down to €8,766.9 million (€8.77 billion, €8.8 billion) of revenue, -9.8% QoQ, with gross margin of 53.0% and diluted EPS of €7.15. But that is not the same as evidence of demand rollover. The reported quarterly sequence shows a revenue trough in Q3 FY2025 at €7,516.0 million (€7.52 billion, €7.5 billion), followed by Q4 FY2025 at €9,718.1 million (€9.72 billion, €9.7 billion), +29.3% QoQ and +4.9% YoY, and then Q1 FY2026 at €8,766.9 million (€8.77 billion, €8.8 billion), still +13.2% YoY. The right interpretation is not linear acceleration, but a higher plateau than the 2024 digestion period, when Q1 FY2024 revenue was €5,290.0 million (€5.29 billion, €5.3 billion), -26.9% QoQ and -21.6% YoY. A stock that trades the Q4 EPS miss as if the 2026 revenue base has cracked is ignoring the YoY step-up embedded in the most recent history.

The capacity story explains why the margin guide can look mundane while the strategic signal is not. Management guided the next quarter to net revenue between €8.2 billion and €8.9 billion with gross margin between 51% and 53%, and for the full year to €34 billion to €39 billion, with gross margin 51% to 53% and annualized effective tax rate of 17%. On its face, a 51% to 53% gross margin band does not scream upward revision against Q4 FY2025 at 52.2% and Q1 FY2026 at 53.0%. But ASML is also explicitly preserving its 2030 framework. Fouquet’s exact wording matters because it is a reaffirmation rather than a new aspiration: “We still expect for 2030 revenue between EUR 44 billion and EUR 60 billion with a gross margin of 56% to 60%.” The market may be over-penalizing a 2026 gross-margin band that reflects mix and timing while underweighting the fact that management left the terminal margin range at 56% to 60%, above the 52.8% gross margin it says it delivered in 2025.

The bridge to that terminal framework is not just more wafer-fab equipment spending; it is lithography content intensity. Dassen said EUV grew 39% compared with 2024, supported by “both more tools” and “significantly higher sales price of the tools,” with most low-NA systems sold in 2025 being “3,800 tools” that raised productivity from 160 wafers per hour to 220 wafers per hour. That phrase carries pricing power, not merely volume growth, and it is central to the investment case. If productivity rises from 160 wafers per hour to 220 wafers per hour and ASML receives a commensurate sales-price increase, customers are paying for throughput economics rather than simply deferring capacity until pricing improves. That is why a revenue beat paired with EPS miss is less damaging than it looks: the product cycle is moving toward higher-value configurations, while short-term EPS can be pushed around by mix, operating cost, and timing that the data pack does not fully disaggregate.

That same product-cycle argument becomes more durable when it includes DUV and metrology rather than relying on High-NA EUV alone. Fouquet was explicit that High NA “is not going to be the tool that provide the capacity of EUV in 2026, '27,” but is the tool enabling customers to move to more advanced technology around “‘28-'29,” with importance for DRAM. The hedge here is real and should be taken seriously: High NA is not the 2026 capacity answer. But the non-High-NA portfolio is not static. Fouquet said immersion’s 2150 delivers sub-nanometer accuracy and more than 300 wafer per hour, while the NXT:870B KrF system reaches more than 400 wafer per hour. He also said metrology inspection grew by almost 30% in 2025. Those numbers turn the story from a single-tool bet into a platform bet. The company is monetizing productivity in EUV at 220 wafers per hour, immersion at more than 300 wafer per hour, KrF at more than 400 wafer per hour, and metrology at almost 30% growth, which gives customers multiple paths to capacity and yield improvement before High NA carries the advanced-node roadmap in ‘28-'29.

The customer read-through is therefore more specific than “AI capex helps ASML.” For TSMC, Samsung, and Intel, the relevant signal is that EUV and immersion combined contributed 90% of ASML systems revenue, which means leading-edge and advanced process capacity are dominating the systems mix. For Micron and SK Hynix, the High-NA timing matters because ASML tied the transition around ‘28-'29 to DRAM, while 2025 end use was memory at 34% and logic at 66%; memory is meaningful, but not yet the majority of the mix. SMIC remains a different read-through because it is listed as a DUV scanner customer with no EUV, and ASML expects the China business to be around 20% of total sales this year, down from 29% of total sales and 33% of system sales in the referenced period. Dassen added that 20% still implies, at the midpoint, close to €7.5 billion of sales. That is the crucial second-order point: the China reduction is a mix normalization rather than disappearance, and the €7.5 billion midpoint reference leaves DUV suppliers and China-exposed service streams with material activity even as EUV demand remains centered on non-China leading-edge customers.

The supplier implications follow the same split between near-term DUV/EUV execution and later High-NA adoption. Gudeng Precision’s High-NA EUV reticle pod development and Marketech International’s EUV lithography sub-system module contract manufacturing are levered to the EUV and High-NA roadmap, but the timing cue is explicit: High NA is not the EUV capacity tool for 2026 and ‘27, with the advanced-technology shift around ‘28-'29. Pfeiffer Vacuum and VAT Group remain tied to EUV tool build through high-vacuum and equipment exposure, while Canatu’s carbon nanotube EUV pellicles at 97% transmission, Corning ULE glass photomask substrates for EUV, and Mitsui Chemicals EUV pellicles are more directly attached to EUV ecosystem scaling. The magnitude that matters for all of them is not Q4 revenue alone, but ASML’s statement that EUV grew 39% compared with 2024 and installed base business increased 26%. A 26% installed-base increase is especially important for suppliers and customers because it says the aftermarket expands with the deployed fleet, not just with new-system shipment timing.

Compared with wafer-fab-equipment peers, ASML’s print also argues that lithography scarcity is still a different profit pool. The peers table shows the latest reported gross margins at 46.2% for 7751.T, 46.8% for TOELY, 31.6% for 6361.T, 25.0% for 6302.T, 40.5% for 7731.T, 40.8% for 7735.T, 32.0% for 6728.T, and 39.4% for 6525.T. ASML’s Q4 FY2025 gross margin was 52.2%, Q1 FY2026 was 53.0%, and its 2025 company basis was 52.8%. The comparison is not that every lithography datapoint is accelerating, since 7751.T revenue YoY was +3.3% and TOELY was +10.6% while ASML’s Q4 FY2025 quarterly-history revenue YoY was +4.9%. The comparison is that ASML’s margin structure sits above the listed peer gross-margin set while its full-year 2026 revenue guide of €34 billion to €39 billion still contemplates growth at the midpoint after a 2025 base described by management as €32.7 billion. That is why the EPS miss should not automatically compress the long-duration multiple if the market accepts the 2030 gross-margin range of 56% to 60%.

The call delivery reinforces the idea that management is not euphoric about the next few quarters, but it was more disciplined than the headline EPS miss implies. The tone history shows Q4 FY2025 sentiment of 0.20, guidance_tone of 0.18, tone_confidence of 0.61, prepared_sentiment of 0.26, qa_sentiment of -0.01, ai_optimism of 0.12, uncertainty of 45.0, and qa_evasiveness of 26.2. That is not a promotional call: QA sentiment was slightly negative at -0.01, and ai_optimism was only 0.12. Yet uncertainty at 45.0 was below Q1 FY2025 at 64.7 and below Q3 FY2025 at 105.6, while tone_confidence at 0.61 was above Q1 FY2025 at 0.42, Q2 FY2025 at 0.36, and Q3 FY2025 at 0.50. In other words, management sounded muted but numerically bounded. The print’s message is not “everything is accelerating”; it is that management put hard ranges around 2026 and reaffirmed 2030 without the elevated uncertainty that characterized Q3 FY2025.

That call tone matters because the company is also managing capacity internally, not just asking suppliers and customers to absorb a smooth upcycle. Fouquet discussed a people-plan adjustment where “the difference between the 1,600 and 1,700 is 100 people coming out of IT,” and also said that out of 3,000 people, ASML had already created 1,400 positions. Those numbers are not large enough in this data pack to build a cost-savings model, and the company did not provide one here, so they should not be over-monetized. But they do support the idea that ASML is pruning at the margin while still building for the roadmap. Combined with a proposed total dividend of €7.50, an interim dividend of €1.60 per ordinary share in Q1, and €7.6 billion executed out of a €12 billion program, capital return is continuing while the company preserves capacity optionality. The tension is exactly what an investor should want at this stage of the cycle: not an indiscriminate hiring surge, and not a retreat from 2030.

The bear case is not imaginary, and it should be framed numerically. EPS missed by -5.4% despite revenue beating by +3.8%, and the next-quarter revenue guide of €8.2 billion to €8.9 billion sits below the Q4 FY2025 quarterly-history revenue of €9,718.1 million (€9.72 billion, €9.7 billion). Gross margin guidance of 51% to 53% also leaves no near-term evidence that margins are already moving toward the 56% to 60% 2030 range. China exposure is stepping down from 29% of total sales to approximately 20% this year, and from 33% of system sales in the referenced period, which reduces one source of recent demand support even if the midpoint is still close to €7.5 billion of sales. Those are real conflicts in the data: near-term EPS and China mix argue for caution, while EUV growth of 39%, installed base growth of 26%, metrology growth of almost 30%, and the 2030 framework argue for patience. The reason to lean positive is that the negative numbers are mostly about mix, timing, and comparison base, while the positive numbers describe lithography intensity and customer roadmap dependency.

What to watch next is therefore concrete. For the next quarter, the thesis is confirmed if net revenue lands within or above €8.2 billion to €8.9 billion and gross margin holds within or above 51% to 53%; it breaks if revenue falls below €8.2 billion or gross margin falls below 51%, because that would turn the EPS miss into an operating-leverage problem rather than a quarterly mix issue. For the full year, the key checkpoint is whether management keeps the €34 billion to €39 billion revenue range, 51% to 53% gross margin, and 17% annualized effective tax rate intact; a cut to any of those would undermine the view that 2026 is a bridge year. On mix, watch whether China stays near approximately 20% of total sales and whether management still describes that as close to €7.5 billion at the midpoint, because a sharper fall would pressure DUV and installed-base assumptions. On technology, the confirming datapoints are EUV growth remaining framed against the 39% 2025 comparison, installed base growth tracking the 26% reference, metrology inspection retaining momentum after almost 30% growth in 2025, and no change to the High-NA timing around ‘28-'29. The stock should work if investors shift from punishing the -5.4% EPS surprise to underwriting the €44 billion to €60 billion 2030 revenue range with 56% to 60% gross margin; it should not if the next report shows the 51% to 53% margin bridge has failed before the bridge even starts.